Integer Holdings Co. (ITGR) Holdings Trimmed by HBK Investments L P

HBK Investments L P decreased its holdings in Integer Holdings Co. (NYSE:ITGR) by 17.0% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 12,696 shares of the medical equipment provider’s stock after selling 2,604 shares during the quarter. HBK Investments L P’s holdings in Integer were worth $575,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in ITGR. American Century Companies Inc. purchased a new stake in shares of Integer during the 3rd quarter valued at about $3,788,000. Swiss National Bank increased its position in shares of Integer by 4.0% during the 3rd quarter. Swiss National Bank now owns 47,100 shares of the medical equipment provider’s stock valued at $2,409,000 after purchasing an additional 1,800 shares during the last quarter. BNP Paribas Arbitrage SA increased its position in shares of Integer by 47.0% during the 3rd quarter. BNP Paribas Arbitrage SA now owns 15,716 shares of the medical equipment provider’s stock valued at $804,000 after purchasing an additional 5,027 shares during the last quarter. Municipal Employees Retirement System of Michigan increased its position in shares of Integer by 60.8% during the 3rd quarter. Municipal Employees Retirement System of Michigan now owns 10,580 shares of the medical equipment provider’s stock valued at $541,000 after purchasing an additional 4,000 shares during the last quarter. Finally, Rhumbline Advisers increased its position in shares of Integer by 2.0% during the 3rd quarter. Rhumbline Advisers now owns 61,908 shares of the medical equipment provider’s stock valued at $3,167,000 after purchasing an additional 1,235 shares during the last quarter. 95.82% of the stock is owned by hedge funds and other institutional investors.

Several equities research analysts have recently commented on ITGR shares. Zacks Investment Research raised shares of Integer from a “sell” rating to a “buy” rating and set a $51.00 price target for the company in a research report on Wednesday, December 27th. TheStreet raised shares of Integer from a “c+” rating to a “b” rating in a research report on Monday, March 12th. Finally, ValuEngine raised shares of Integer from a “buy” rating to a “strong-buy” rating in a research report on Wednesday, March 7th. Five research analysts have rated the stock with a hold rating, one has issued a buy rating and one has issued a strong buy rating to the company. The stock currently has an average rating of “Hold” and a consensus price target of $51.00.

Shares of Integer stock opened at $56.45 on Friday. Integer Holdings Co. has a 52-week low of $33.90 and a 52-week high of $58.54. The company has a market cap of $1,800.81, a PE ratio of 20.09, a PEG ratio of 1.14 and a beta of 0.99. The company has a debt-to-equity ratio of 1.77, a quick ratio of 1.46 and a current ratio of 2.55.

Integer (NYSE:ITGR) last released its quarterly earnings results on Thursday, February 22nd. The medical equipment provider reported $0.96 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.79 by $0.17. The firm had revenue of $390.50 million during the quarter, compared to analyst estimates of $358.42 million. Integer had a net margin of 4.56% and a return on equity of 11.13%. The business’s revenue for the quarter was up 8.6% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.87 EPS. sell-side analysts expect that Integer Holdings Co. will post 3.3 earnings per share for the current fiscal year.

In related news, CEO Joseph W. Dziedzic sold 3,182 shares of the business’s stock in a transaction that occurred on Wednesday, January 3rd. The stock was sold at an average price of $44.89, for a total transaction of $142,839.98. Following the completion of the transaction, the chief executive officer now directly owns 21,351 shares in the company, valued at approximately $958,446.39. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, EVP Joseph F. Flanagan sold 799 shares of the business’s stock in a transaction that occurred on Wednesday, January 3rd. The shares were sold at an average price of $44.89, for a total value of $35,867.11. Following the transaction, the executive vice president now owns 4,243 shares of the company’s stock, valued at $190,468.27. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 14,064 shares of company stock valued at $631,333. 4.80% of the stock is currently owned by corporate insiders.

COPYRIGHT VIOLATION WARNING: “Integer Holdings Co. (ITGR) Holdings Trimmed by HBK Investments L P” was first published by Ticker Report and is the sole property of of Ticker Report. If you are reading this piece of content on another website, it was stolen and reposted in violation of U.S. & international trademark & copyright legislation. The legal version of this piece of content can be read at https://www.tickerreport.com/banking-finance/3298810/integer-holdings-co-itgr-holdings-trimmed-by-hbk-investments-l-p.html.

About Integer

Greatbatch, Inc is a developer and manufacturer of medical devices and components. The Company operates through two segments: Greatbatch Medical and QiG Group (QiG). Greatbatch Medical designs and manufactures products where the Company either owns the intellectual property or has unique manufacturing and assembly expertise.

Want to see what other hedge funds are holding ITGR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Integer Holdings Co. (NYSE:ITGR).

Institutional Ownership by Quarter for Integer (NYSE:ITGR)

Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Ichor  Stock Price Up 8.7%
Ichor Stock Price Up 8.7%
MongoDB  Trading 7.1% Higher
MongoDB Trading 7.1% Higher
Intercept Pharmaceuticals  Trading Up 5.9%
Intercept Pharmaceuticals Trading Up 5.9%
Analysts Expect BB&T  Will Post Quarterly Sales of $2.91 Billion
Analysts Expect BB&T Will Post Quarterly Sales of $2.91 Billion
First Financial Bank  Receives $30.00 Consensus PT from Brokerages
First Financial Bank Receives $30.00 Consensus PT from Brokerages
Signature Bank  Given Consensus Recommendation of “Buy” by Brokerages
Signature Bank Given Consensus Recommendation of “Buy” by Brokerages


© 2006-2018 Ticker Report. Google+.